17053348

Source:http://linkedlifedata.com/resource/pubmed/id/17053348

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019699, umls-concept:C0021761, umls-concept:C0030705, umls-concept:C0035820, umls-concept:C0079611, umls-concept:C0083032, umls-concept:C0087111, umls-concept:C1332714, umls-concept:C1512900
pubmed:issue	16
pubmed:dateCreated	2006-10-20
pubmed:abstractText	To investigate immunological changes during CD4-guided therapy interruption in HIV(+) patients who suspended HAART.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-7, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-7
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0269-9370
pubmed:author	pubmed-author:BorghiVanniV, pubmed-author:BugariniRobertoR, pubmed-author:CossarizzaAndreaA, pubmed-author:EspositoRobertoR, pubmed-author:FerraresiRobertaR, pubmed-author:LugliEnricoE, pubmed-author:MussiniCristinaC, pubmed-author:NasiMilenaM, pubmed-author:NemesElisaE, pubmed-author:PintiMarcelloM, pubmed-author:PratiFrancescaF
pubmed:issnType	Print
pubmed:day	24
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2021-32
pubmed:meshHeading	pubmed-meshheading:17053348-Adult, pubmed-meshheading:17053348-Anti-HIV Agents, pubmed-meshheading:17053348-Antiretroviral Therapy, Highly Active, pubmed-meshheading:17053348-Apoptosis, pubmed-meshheading:17053348-Biological Markers, pubmed-meshheading:17053348-CD4 Lymphocyte Count, pubmed-meshheading:17053348-CD4-Positive T-Lymphocytes, pubmed-meshheading:17053348-CD8-Positive T-Lymphocytes, pubmed-meshheading:17053348-Cell Differentiation, pubmed-meshheading:17053348-Drug Administration Schedule, pubmed-meshheading:17053348-Female, pubmed-meshheading:17053348-HIV Infections, pubmed-meshheading:17053348-Humans, pubmed-meshheading:17053348-Immunophenotyping, pubmed-meshheading:17053348-Interleukin-7, pubmed-meshheading:17053348-Longitudinal Studies, pubmed-meshheading:17053348-Lymphocyte Activation, pubmed-meshheading:17053348-Male, pubmed-meshheading:17053348-Middle Aged, pubmed-meshheading:17053348-Receptors, Interleukin-7, pubmed-meshheading:17053348-T-Lymphocyte Subsets, pubmed-meshheading:17053348-Viral Load
pubmed:year	2006
pubmed:articleTitle	Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
pubmed:affiliation	Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't